Australia markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
61.99-2.12 (-3.31%)
As of 11:03AM EST. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
Total revenue
75,614
8,091
10,668
2,708
Operating expenses
Research development
268,247
148,472
100,229
62,512
Selling general and administrative
59,702
37,598
29,131
21,693
Total operating expenses
327,949
186,070
129,360
84,205
Operating income or loss
-252,335
-177,979
-118,692
-81,497
Total other income/expenses net
-8,714
-5,061
-212
83
Income before tax
-256,554
-174,529
-116,364
-80,776
Income tax expense
233
154
-480
-10,924
Income from continuing operations
-256,787
-174,683
-115,884
-69,852
Net income
-256,787
-174,683
-115,884
-69,852
Net income available to common shareholders
-256,787
-174,683
-115,789
-69,852
Basic EPS
-
-5.76
-1.52
-0.72
Diluted EPS
-
-5.76
-1.52
-0.72
Basic average shares
-
30,350
76,050
96,913
Diluted average shares
-
30,350
76,050
96,913
EBITDA
-
-173,462
-115,936
-81,065